Intelligence · Patents
Patents expiring in 2034
Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.
- Patents
- 1,452
Quick answer
1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 8716313
Crystalline forms of a biphenyl compound
granted -
US 8716301
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 8716287
Pharmaceutical compounds
granted -
US 8716258
Regulation of metabolism by miR-378
granted -
US 8716246
Azuvirin peptides
granted -
US 8716279
Pharmaceutical compositions of clonazepam and method of use thereof
granted -
US 8716215
Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
granted -
US 8716030
Means for the inhibition of anti-β1-adrenergic receptor antibodies
granted -
US 8716017
Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells
granted -
US 8715968
Methods and reagents for modulating cholesterol levels
granted -
US 8715949
Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components
granted -
US 8715710
Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron
granted -
US 8715689
Chimeric west nile/dengue viruses
granted -
US 8715682
Means for the inhibition of anti-beta1-adrenergic receptor antibodies
granted -
US 8715679
Pili from Mycobacterium tuberculosis
granted -
US 8715645
Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same
granted -
US 8722889
Azaindoles useful as inhibitors of JAK and other protein kinases
granted -
US 8722077
Drug delivery coating for use with a stent
granted -
US 8722667
Compositions and methods for inhibiting the proliferation of cells
granted -
US 8722616
Anti-HIV peptides and methods of use thereof
granted -
US 8722884
Pyrimidine derivatives for the treatment of abnormal cell growth
granted -
US 8722895
Prolyl hydroxylase inhibitors and method of use
granted -
US 8721620
Swallowable drug delivery device and methods of drug delivery
granted -
US 8722939
Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis
granted -
US 8722896
Prokineticin receptor antagonists and uses thereof
granted -
US 8722871
VMP-like sequences of pathogenic borrelia species and strains
granted -
US 8722662
Heterocyclic compounds
granted -
US 8725266
Method for stimulating retinal response using photoactive devices
granted -
US 8722894
1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
granted -
US 8722738
Acetycysteine compositions and methods of use thereof
granted -
US 8722660
Heterocyclic compound
granted -
US 8722863
Solid state forms of fidaxomycin and processes for preparation thereof
granted -
US 8722708
Substituted isoindolines as aspartyl protease inhibitors
granted -
US 8722732
Oligomer-calcimimetic conjugates and related compounds
granted -
US 8722722
Raltegravir salts and crystalline forms thereof
granted -
US 8722716
Isoxazole treatments for diabetes
granted -
US 8722704
Modulators of ATP-binding cassette-transporters
granted -
US 8722082
Lipids and compositions for the delivery of therapeutics
granted -
US 8722653
Method for treating uterine fibroids
granted -
US 8722646
High concentration chitosan-nucleic acid polyplex compositions
granted -
US 8722645
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
granted -
US 8722628
Autophagy-inducing peptide
granted -
US 8722046
Human monoclonal antibodies protective against bubonic plague
granted -
US 8722063
Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
granted -
US 8722132
Application of a coating on a medical device
granted -
US 8722032
Thiol-selective water-soluble polymer derivatives
granted -
US 8722084
Controlled release preparation
granted -
US 8729026
Method for inhibiting autophagy of motor neurons
granted
Frequently asked questions
How many pharma patents expire in 2034?
1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.